Table 2

Performance of noninvasive tests for the diagnosis of definite NASH

Predefined cutoff pointsCohort-specific cutoff points
CutoffSensitivitySpecificityPPVNPVCutoffSensitivitySpecificityPPVNPV
Cohort-specific model* <−0.941 >−0.123 74 (61–84) 74 (63–83) 70 (58–81) 77 (66–86) 0.255 55 (44–66) 93 (86–97) 86 (73–94) 73 (64–80) 
ALT 40 units/L 66 (55–75) 72 (64–80) 63 (53–73) 74 (65–82) 31 units/L 83 (74–90) 61 (52–70) 61 (52–70) 83 (74–90) 
CK-18 N/A — — — — 241 units/L 63 (52–73) 80 (71–86) 70 (59–80) 74 (66–81) 
HAIR 96 (90–99) 12 (7–20) 47 (39–55) 81 (54–96) 57 (45–68) 77 (68–85) 66 (54–77) 69 (60–77) 
OWLiver 0.500 34 (24–45) 87 (79–92) 64 (49–78) 65 (57–72) 0.016 66 (55–76) 69 (60–77) 60 (49–70) 74 (65–82) 
NashTest 2 0.250 92 (83–96) 29 (21–38) 49 (41–57) 82 (67–92) 0.410 71 (60–80) 58 (48–67) 56 (46–65) 73 (62–82) 
BARD 98 (92–100) 5 (2–10) 43 (36–50) 75 (35–97) 98 (92–100) 5 (2–10) 43 (36–50) 75 (35–97) 
Predefined cutoff pointsCohort-specific cutoff points
CutoffSensitivitySpecificityPPVNPVCutoffSensitivitySpecificityPPVNPV
Cohort-specific model* <−0.941 >−0.123 74 (61–84) 74 (63–83) 70 (58–81) 77 (66–86) 0.255 55 (44–66) 93 (86–97) 86 (73–94) 73 (64–80) 
ALT 40 units/L 66 (55–75) 72 (64–80) 63 (53–73) 74 (65–82) 31 units/L 83 (74–90) 61 (52–70) 61 (52–70) 83 (74–90) 
CK-18 N/A — — — — 241 units/L 63 (52–73) 80 (71–86) 70 (59–80) 74 (66–81) 
HAIR 96 (90–99) 12 (7–20) 47 (39–55) 81 (54–96) 57 (45–68) 77 (68–85) 66 (54–77) 69 (60–77) 
OWLiver 0.500 34 (24–45) 87 (79–92) 64 (49–78) 65 (57–72) 0.016 66 (55–76) 69 (60–77) 60 (49–70) 74 (65–82) 
NashTest 2 0.250 92 (83–96) 29 (21–38) 49 (41–57) 82 (67–92) 0.410 71 (60–80) 58 (48–67) 56 (46–65) 73 (62–82) 
BARD 98 (92–100) 5 (2–10) 43 (36–50) 75 (35–97) 98 (92–100) 5 (2–10) 43 (36–50) 75 (35–97) 

Data are % (95% CI). N/A, not applicable.

*

Model was = 0.0941 × (HOMA-IR) + 0.0039 × (CK-18) − 1.8647.

Close Modal

or Create an Account

Close Modal
Close Modal